TABLE 1. SELECT FDA AND ICH GUIDANCE DOCUMENTS RELEVANT TO VACCINE DEVELOPMENT
TABLE 2. LOT-RELEASE TESTING GUIDELINES
TABLE 3. TOP FIVE BEST SELLING VACCINE PRODUCTS, 2015 & 2022
TABLE 4. TOP FIVE R&D VACCINE PRODUCTS UNDER PIPELINE, 2015 & 2022
TABLE 5. GLOBAL VACCINES MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 6. CONJUGATE VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. LIST OF COMMERCIAL INACTIVATED VACCINES
TABLE 8. INACTIVATED VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. LIST OF COMMERCIAL LIVE ATTENUATED VACCINES
TABLE 10. LIVE ATTENUATED VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. TOXOID VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. LIST OF COMMERCIAL RECOMBINANT VACCINES
TABLE 13. RECOMBINANT VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. OTHER VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL VACCINES MARKET, BY END USE, 2016-2023 ($MILLION)
TABLE 16. PEDIATRIC VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. RECOMMENDED IMMUNIZATION SCHEDULE, U.S., 2017
TABLE 18. ADULT VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. TRAVELER VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL VACCINES MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 21. COMPANY PRODUCT ANALYSIS OF PNEUMOCOCCAL VACCINES IN U.S.
TABLE 22. VACCINES MARKET FOR PNEUMOCOCCAL DISEASE, BY REGION, 2016-2023 ($MILLION)
TABLE 23. INFLUENZA VACCINE RECOMMENDATIONS BY CDC, 2016-2017
TABLE 24. COMPANY PRODUCT ANALYSIS OF INFLUENZA VACCINES IN U.S.
TABLE 25. VACCINES MARKET FOR INFLUENZA, BY REGION, 2016-2023 ($MILLION)
TABLE 26. HUMAN PAPILLOMA VIRUS RECOMMENDATIONS BY CDC, 2016-2017
TABLE 27. COMPANY PRODUCT ANALYSIS OF HUMAN PAPILLOMA VACCINES IN U.S.
TABLE 28. VACCINES MARKET FOR HUMAN PAPILLOMA VIRUS, BY REGION, 2016-2023 ($MILLION)
TABLE 29. COMPANY PRODUCT ANALYSIS OF MENINGOCOCCAL VACCINES IN U.S.
TABLE 30. MENINGOCOCCAL DISEASE VACCINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 31. COMPANY PRODUCT ANALYSIS OF ROTAVIRUS VACCINES IN U.S.
TABLE 32. ROTAVIRUS VACCINE RECOMMENDATIONS BY CDC, 2016-2017
TABLE 33. VACCINES MARKET FOR ROTAVIRUS, BY REGION, 2016-2023 ($MILLION)
TABLE 34. COMPANY PRODUCT ANALYSIS OF VARICELLA VACCINES IN U.S.
TABLE 35. VACCINES MARKET FOR VARICELLA, BY REGION, 2016-2023 ($MILLION)
TABLE 36. COMPANY PRODUCT ANALYSIS OF DPT VACCINES IN U.S.
TABLE 37. VACCINES MARKET FOR DPT, BY REGION, 2016-2023 ($MILLION)
TABLE 38. COMPANY PRODUCT ANALYSIS OF POLIO VACCINES IN U.S.
TABLE 39. VACCINES MARKET FOR POLIO, BY REGION, 2016-2023 ($MILLION)
TABLE 40. COMPANY PRODUCT ANALYSIS OF HEPATITIS VACCINES IN U.S.
TABLE 41. VACCINES MARKET FOR HEPATITIS, BY REGION, 2016-2023 ($MILLION)
TABLE 42. COMPANY PRODUCT ANALYSIS OF MMR VACCINES IN U.S.
TABLE 43. VACCINES MARKET FOR MMR, BY REGION, 2016-2023 ($MILLION)
TABLE 44. COMPANY PRODUCT ANALYSIS OF OTHER VACCINES IN U.S.
TABLE 45. VACCINES MARKET FOR OTHER INDICATIONS, BY REGION, 2016-2023 ($MILLION)
TABLE 46. VACCINES MARKET, BY REGION ($MILLION)
TABLE 47. NORTH AMERICA VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 48. NORTH AMERICA VACCINES MARKET, BY TECHNOLOGY ($MILLION)
TABLE 49. NORTH AMERICA VACCINES MARKET, BY INDICATION ($MILLION)
TABLE 50. NORTH AMERICA VACCINES MARKET, BY END USE ($MILLION)
TABLE 51. EUROPE VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 52. EUROPE VACCINES MARKET, BY TECHNOLOGY ($MILLION)
TABLE 53. EUROPE VACCINES MARKET, BY INDICATION ($MILLION)
TABLE 54. EUROPE VACCINES MARKET, BY END USE ($MILLION)
TABLE 55. ASIA-PACIFIC VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 56. ASIA-PACIFIC VACCINES MARKET, BY TECHNOLOGY ($MILLION)
TABLE 57. ASIA-PACIFIC VACCINES MARKET, BY INDICATION ($MILLION)
TABLE 58. ASIA-PACIFIC VACCINES MARKET, BY END USE ($MILLION)
TABLE 59. LAMEA VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 60. LAMEA VACCINES MARKET, BY TECHNOLOGY ($MILLION)
TABLE 61. LAMEA VACCINES MARKET, BY INDICATION ($MILLION)
TABLE 62. LAMEA VACCINES MARKET, BY END USE ($MILLION)
TABLE 63. ASTELLAS: COMPANY SNAPSHOT
TABLE 64. ASTELLAS: PRODUCT PORTFOLIO
TABLE 65. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 66. ASTRAZENECA: OPERATING SEGMENTS
TABLE 67. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 68. CSL: COMPANY SNAPSHOT
TABLE 69. CSL: OPERATING SEGMENTS
TABLE 70. CSL: PRODUCT PORTFOLIO
TABLE 71. EMERGENT BIOSOLUTIONS: COMPANY SNAPSHOT
TABLE 72. EMERGENT BIOSOLUTIONS: OPERATING SEGMENTS
TABLE 73. EMERGENT BIOSOLUTIONS: PRODUCT PORTFOLIO
TABLE 74. GSK: COMPANY SNAPSHOT
TABLE 75. GSK: OPERATING SEGMENTS
TABLE 76. GSK: PRODUCT PORTFOLIO
TABLE 77. J&J: COMPANY SNAPSHOT
TABLE 78. J&J: OPERATING SEGMENTS
TABLE 79. J&J: PRODUCT PORTFOLIO
TABLE 80. MERCK: COMPANY SNAPSHOT
TABLE 81. MERCK: OPERATING SEGMENTS
TABLE 82. MERCK: PRODUCT PORTFOLIO
TABLE 83. PFIZER: COMPANY SNAPSHOT
TABLE 84. PFIZER: OPERATING SEGMENTS
TABLE 85. PFIZER: PRODUCT PORTFOLIO
TABLE 86. SANOFI: COMPANY SNAPSHOT
TABLE 87. SANOFI: OPERATING SEGMENTS
TABLE 88. SANOFI: PRODUCT PORTFOLIO
TABLE 89. SERUM INSTITUTE OF INDIA: COMPANY SNAPSHOT
TABLE 90. SERUM INSTITUTE OF INDIA: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 1. SNAPSHOT OF GLOBAL VACCINES MARKET, 2017-2023
FIGURE 2. SNAPSHOT OF GLOBAL VACCINES, BY REGION
FIGURE 3. MARKET SEGMENTATION
FIGURE 4. TOP INVESTMENT POCKETS
FIGURE 5. TOP WINNING STRATEGIES, 2014-2017 (%)
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 7. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 8. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 9. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 10. BARGAINING POWER OF BUYERS
FIGURE 11. BARGAINING POWER OF SUPPLIERS
FIGURE 12. THREAT OF NEW ENTRANTS
FIGURE 13. THREAT OF SUBSTITUTION
FIGURE 14. COMPETITIVE RIVALRY
FIGURE 15. FDA REGULATION ANALYSIS
FIGURE 16. VACCINE APPROVAL PROCESS
FIGURE 17. MARKET SHARE ANALYSIS, 2016
FIGURE 18. CLINICAL TRIALS FOR VACCINES MARKET BY TOP PLAYERS (%)
FIGURE 19. VACCINE CLINICAL TRIAL DEVELOPMENT FOR DIFFERENT INDICATION
FIGURE 20. RESTRAINTS AND DRIVERS
FIGURE 21. VACCINE DEVELOPMENT CYCLE
FIGURE 22. GLOBAL VACCINES MARKET: TECHNOLOGY SEGMENTATION
FIGURE 23. STATISTICAL ANALYSIS OF APPLICATION OF CONJUGATE VACCINES IN THE PREVENTION OF DISEASES
FIGURE 24. GLOBAL VACCINES MARKET: END USE SHARE ANALYSIS, 2016
FIGURE 25. TYPES OF TRAVEL VACCINES IN UK
FIGURE 26. PNEUMOCOCCAL DISEASES AMONG CHILDREN AGED <5 YEARS IN U.S.
FIGURE 27. U.S. VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 28. CANADA VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 29. MEXICO VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 30. UK VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 31. FRANCE VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 32. GERMANY VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 33. ITALY VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 34. SPAIN VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 35. REST OF EUROPE VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 36. JAPAN VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 37. CHINA VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 38. INDIA VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 39. AUSTRALIA VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 40. REST OF ASIA PACIFIC VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 41. BRAZIL VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 42. ARGENTINA VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 43. TURKEY VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 44. SOUTH AFRICA VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 45. REST OF LAMEA VACCINES MARKET, 2016-2023 ($MILLION)
FIGURE 46. ASTELLAS: NET SALES, 2014-2016 ($MILLION)
FIGURE 47. ASTELLAS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 48. ASTRAZENECA: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. ASTRAZENECA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 50. CSL: NET SALES, 2014-2016 ($MILLION)
FIGURE 51. CSL: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 52. CSL: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 53. EMERGENT: NET SALES, 2014-2016 ($MILLION)
FIGURE 54. GSK: NET SALES, 2014-2016 ($MILLION)
FIGURE 55. GSK: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 56. GSK: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 57. J&J: NET SALES, 2014-2016 ($MILLION)
FIGURE 58. J&J: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 59. J&J: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 60. MERCK: NET SALES, 2014-2016 ($MILLION)
FIGURE 61. MERCK: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 62. MERCK: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 63. PFIZER: NET SALES, 2014-2016 ($MILLION)
FIGURE 64. PFIZER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 65. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 66. SANOFI: NET SALES, 2014-2016 ($MILLION)
FIGURE 67. SANOFI: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 68. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2016 (%)